Reduction of elevated lipids and low-density lipoprotein oxidation in serum of individuals with subclinical hypoxia and oxidative stress supplemented with lycosome formulation of docosahexaenoic acid

Evaluation of Antioxidant Therapeutic Value of ACE Inhibitor as Adjunct Therapy on Type 2 Diabetes Mellitus Patients with Cardiovascular Disease

Diabetes mellitus (DM) is believed to promote oxidative stress, which potentially provokes and accelerates complications in conditions such as atherosclerotic cardiovascular, peripheral arterial, and cerebrovascular diseases. In this study, we evaluated the antioxidant therapeutic value of adding an angiotensin-converting enzyme (ACE) inhibitor-a low dose of captopril-as adjunct therapy to the treatment regimen of Type 2 diabetes mellitus (T2DM). Participants were distributed among two different groups: control and treated. T2DM patients in the treated group (group 2) were given a supplement of the ACE inhibitor capotopril, 12.5 mg/day, in addition to standard treatment. All subjects were interviewed for clinical examination. All patients in group 2 were re-examined monthly for 3 months to evaluate FBS, HbA1c, MDA, total GSH, reduced GSH, GSSG, and ox-LDL. All parameters were repeated for patients in group 2 after 1 and 3 months. The study showed improvements in the glycemic and oxidative stress status with the addition of a low dose of captopril-not very prominent but statistically significant. Reduced GSH decreased by 73.6% (P = 0.016) and the TBARS level was decreased by 58.3% (P = 0.018) after 3 months of treatment, while ox-LDL was decreased by 26.4% (P = 0.036) at the end of treatment. In summary, the clinical improvements in the disease indices toward normal levels make the use of low doses of ACE inhibitors as adjunct therapy in T2DM worth pursuing. Thus, investigations directed at preventing or protecting against oxidative damage may open a new window for treatment of diabetes mellitus.

Selenium nanoparticles are more efficient than sodium selenite in reducing the toxicity of aflatoxin B1 in Japanese quail

Background

Dietary selenium (Se), as an antioxidant element, plays a protective role in aflatoxin B₁ (AFB₁) toxicosis in poultry.

Objectives

To compare the effects of sodium selenite (SS) and Se nanoparticles (SeNPs) against AFB₁‐induced toxicity on growth performance, carcass traits, immune response, antioxidant status and serum lipid concentrations in Japanese broiler quails.

Methods

A total of 540 quails were divided into six treatments, each with six replicates and 15 birds per replicate at 24 days of age and reared for 21 days. Treatments included: (1) a basal diet without Se and AFB₁ (negative control; NC); (2) NC + 1.0 mg/kg AFB₁ (positive control; PC); (3) PC + 0.2 mg/kg Se as SS; (4) PC + 0.5 mg/kg Se as SS; (5) PC + 0.2 mg/kg Se as SeNPs; and (6) PC + 0.5 mg/kg Se as SeNPs.

Results

Treatment with PC diet decreased feed intake and body weight gain and increased feed conversion ratio than the NC diet. The PC diet also atrophied the lymphoid organs and depressed antibody responses against Newcastle disease and avian influenza viruses and sheep red blood cell. Moreover, quails treated with PC diet appeared to have lower serum glutathione peroxidase and thioredoxin reductase activities and disturbed serum lipids than those receiving the NC diet. Dietary Se attenuated these detrimental effects, but failed to completely eliminate them. Additionally, SeNPs performed better than SS in improving thioredoxin reductase activity and antibody titer against sheep red blood cell.

Conclusions

Diet supplementation with SeNPs to provide 0.5 mg/kg of Se is recommended to reduce the AFB₁ toxicosis in broiler quails.